Search

everythinglearnresearchcommunity

for

Search:↓

Deoxycholic acid is effective for reducing chin fat but can cause side effects and serious complications, so careful patient evaluation is needed.

Caffeic acid helps protect rats from the harmful effects of acrylamide.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Ascorbic acid derivatives improve drug delivery systems.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Carboxytherapy can improve skin conditions with few side effects, but results may vary and are not guaranteed.

Activating Nrf2 in skin cells causes skin disease similar to chloracne in mice.

N-WASP is essential for healthy skin and preventing inflammation.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Rhus semialata gall extract and Penta-O-Galloyl-β-D-Glucose may effectively reduce hair loss.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Baricitinib shows promise in treating severe hair loss.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

The compounds tested could potentially treat hair loss and alopecia.

The YH complex, made from certain plant extracts, effectively promotes hair regrowth and could be a potential treatment for hair loss.

Patients with early-onset androgenetic alopecia have a higher risk of metabolic syndrome and carotid arteriosclerosis, suggesting the need for early cardiovascular screening and prevention.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Caffeine and DMG increase calcium influx in hair follicle cells without being toxic.

A new topical treatment for hair loss shows promise by targeting androgen receptors.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

High-concentration cell-free adipose extract reduces scar formation and improves scar appearance.